Vertex Pharmaceuticals Incorporated (FRA:VX1)

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had revenue of $2.96B USD in the quarter ending June 30, 2025, with 12.06% growth. This brings the company's revenue in the last twelve months to $11.42B, up 10.46% year-over-year. In the year 2024, Vertex Pharmaceuticals had annual revenue of $11.02B with 11.66% growth.

• Revenue (ttm): $11.42B
• Revenue Growth: +10.46%
• P/S Ratio: 8.85
• Revenue / Employee: $1.87M
• Employees: 6,100
• Market Cap: 86.00B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.02B	1.15B	11.66%
Dec 31, 2023	9.87B	938.50M	10.51%
Dec 31, 2022	8.93B	1.36B	17.91%
Dec 31, 2021	7.57B	1.37B	22.06%
Dec 31, 2020	6.21B	2.04B	49.08%